Synopsis
Synopsis
0
CEP/COS
0
VMF
0
API
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 278, Tmc
2. Hcl, Rilpivirine
3. Hydrochloride, Rilpivirine
4. R278474
5. Rilpivirine
6. Rilpivirine Hcl
7. Tmc 278
8. Tmc-278
9. Tmc278
1. Rilpivirine Hcl
2. 700361-47-3
3. Tmc278 Hydrochloride
4. Edurant
5. Rilpivirine Hydrochloride [usan]
6. 212wax8kdd
7. Rilpivirine (as Hydrochloride)
8. 700361-47-3 (hcl)
9. Chebi:68602
10. (e)-4-((4-((4-(2-cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile Hydrochloride
11. Benzonitrile, 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)-, Hydrochloride (1:1)
12. 4-[[4-[4-[(e)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile;hydrochloride
13. Unii-212wax8kdd
14. Endurant
15. Edurant (tn)
16. Rilpivirine Monohydrochloride
17. Tmc-278 Hydrochloride
18. Schembl1831067
19. Tmc-278-la
20. Tmc 278. Trade Name Edurant
21. Chembl1628504
22. Dtxsid80220320
23. Bcp13350
24. Rilpivirine Hydrochloride (jan/usan)
25. Rilpivirine Hydrochloride [mi]
26. Akos025149454
27. Rilpivirine Hydrochloride [jan]
28. 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)pyrimidin-2- Yl)amino)benzonitrile
29. Rilpivirine Hydrochloride [vandf]
30. Ac-30620
31. Rilpivirine Hydrochloride [who-dd]
32. D09958
33. Rilpivirine Hydrochloride [orange Book]
34. Juluca Component Rilpivirine Hydrochloride
35. Eviplera Component Rilpivirine Hydrochloride
36. Odefsey Component Rilpivirine Hydrochloride
37. Rilpivirine Hydrochloride Component Of Juluca
38. Q27137040
39. Rilpivirine Hydrochloride Component Of Eviplera
40. Rilpivirine Hydrochloride Component Of Odefsey
41. 4-[[4-[[4-[(e)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile Monohydrochloride
42. 4-{[4-({4-[(e)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile Hydrochloride
43. 4-{[4-({4-[(e)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile Hydrochloride
44. Benzonitrile, 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2- Pyrimidinyl)amino)-, Hydrochloride (1:1)
Molecular Weight | 402.9 g/mol |
---|---|
Molecular Formula | C22H19ClN6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 402.1359723 g/mol |
Monoisotopic Mass | 402.1359723 g/mol |
Topological Polar Surface Area | 97.4 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 607 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Edurant |
PubMed Health | Rilpivirine (By mouth) |
Drug Classes | Antiretroviral Agent |
Active Ingredient | Rilpivirine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 25mg base |
Market Status | Prescription |
Company | Janssen Prods |
2 of 2 | |
---|---|
Drug Name | Edurant |
PubMed Health | Rilpivirine (By mouth) |
Drug Classes | Antiretroviral Agent |
Active Ingredient | Rilpivirine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 25mg base |
Market Status | Prescription |
Company | Janssen Prods |
Edurant, in combination with other antiretroviral medicinal products, is indicated for the treatment of human immunodeficiency virus type 1 (HIV1) infection in antiretroviral treatmentnave patients 12 years of age and older with a viral load 100,000 HIV1 RNA copies/ml.
As with other antiretroviral medicinal products, genotypic resistance testing should guide the use of Edurant.
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)
J05AG05
GDUFA
DMF Review : Complete
Rev. Date : 2019-10-04
Pay. Date : 2019-07-29
DMF Number : 30773
Submission : 2017-01-02
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-03-11
Pay. Date : 2015-09-24
DMF Number : 29301
Submission : 2015-04-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-07
Pay. Date : 2012-12-26
DMF Number : 23824
Submission : 2010-07-19
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-06-15
Pay. Date : 2015-11-02
DMF Number : 29841
Submission : 2015-12-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-05-04
Pay. Date : 2018-03-07
DMF Number : 30423
Submission : 2016-03-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37479
Submission : 2022-09-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26305
Submission : 2012-08-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39552
Submission : 2024-02-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-30
Pay. Date : 2013-07-08
DMF Number : 27253
Submission : 2013-07-24
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?